Our previous research has demonstrated that retinoid X receptor agonists can alleviate cardiomyopathy in streptozotocin‐induced type‐1 diabetes by exerting LKB1‐dependent anti‐fibrotic effects.43 This evidence concerns the gene STK11 and cardiomyopathy.